These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1440 related items for PubMed ID: 20086077

  • 1. Myocardial fatty acid metabolism in health and disease.
    Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC.
    Physiol Rev; 2010 Jan; 90(1):207-58. PubMed ID: 20086077
    [Abstract] [Full Text] [Related]

  • 2. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.
    Zhang L, Keung W, Samokhvalov V, Wang W, Lopaschuk GD.
    Biochim Biophys Acta; 2010 Jan; 1801(1):1-22. PubMed ID: 19782765
    [Abstract] [Full Text] [Related]

  • 3. Targets for modulation of fatty acid oxidation in the heart.
    Lopaschuk GD.
    Curr Opin Investig Drugs; 2004 Mar; 5(3):290-4. PubMed ID: 15083595
    [Abstract] [Full Text] [Related]

  • 4. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
    Fukushima A, Lopaschuk GD.
    Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
    [Abstract] [Full Text] [Related]

  • 5. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED.
    Circ Res; 2021 May 14; 128(10):1487-1513. PubMed ID: 33983836
    [Abstract] [Full Text] [Related]

  • 6. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
    Fukushima A, Lopaschuk GD.
    Biochim Biophys Acta; 2016 Oct 14; 1861(10):1525-34. PubMed ID: 26996746
    [Abstract] [Full Text] [Related]

  • 7. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
    Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD.
    Biochim Biophys Acta; 2011 Jul 14; 1813(7):1333-50. PubMed ID: 21256164
    [Abstract] [Full Text] [Related]

  • 8. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.
    Fillmore N, Mori J, Lopaschuk GD.
    Br J Pharmacol; 2014 Apr 14; 171(8):2080-90. PubMed ID: 24147975
    [Abstract] [Full Text] [Related]

  • 9. The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
    Kerr M, Dodd MS, Heather LC.
    Clin Sci (Lond); 2017 Aug 15; 131(16):2079-2094. PubMed ID: 28739841
    [Abstract] [Full Text] [Related]

  • 10. Alterations in myocardial fatty acid metabolism contribute to ischemic injury in the diabetic.
    Lopaschuk GD.
    Can J Cardiol; 1989 Sep 15; 5(6):315-20. PubMed ID: 2676122
    [Abstract] [Full Text] [Related]

  • 11. Metabolic toxicity of the heart: insights from molecular imaging.
    Iozzo P.
    Nutr Metab Cardiovasc Dis; 2010 Mar 15; 20(3):147-56. PubMed ID: 20031381
    [Abstract] [Full Text] [Related]

  • 12. Fatty Acid Oxidation and Its Relation with Insulin Resistance and Associated Disorders.
    Lopaschuk GD.
    Ann Nutr Metab; 2016 Mar 15; 68 Suppl 3():15-20. PubMed ID: 27931032
    [Abstract] [Full Text] [Related]

  • 13. Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart.
    Bakrania B, Granger JP, Harmancey R.
    J Vis Exp; 2016 Sep 28; (115):. PubMed ID: 27768055
    [Abstract] [Full Text] [Related]

  • 14. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC.
    Coron Artery Dis; 2001 Feb 28; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [Abstract] [Full Text] [Related]

  • 15. Fatty acid oxidation in the heart.
    Grynberg A, Demaison L.
    J Cardiovasc Pharmacol; 1996 Feb 28; 28 Suppl 1():S11-7. PubMed ID: 8891866
    [Abstract] [Full Text] [Related]

  • 16. Paradoxical role of lipid metabolism in heart function and dysfunction.
    Dhalla NS, Elimban V, Rupp H.
    Mol Cell Biochem; 1992 Oct 21; 116(1-2):3-9. PubMed ID: 1480151
    [Abstract] [Full Text] [Related]

  • 17. Fatty acid oxidation in the reperfused ischemic heart.
    Kantor PF, Dyck JR, Lopaschuk GD.
    Am J Med Sci; 1999 Jul 21; 318(1):3-14. PubMed ID: 10408755
    [Abstract] [Full Text] [Related]

  • 18. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A, Milner K, Gupta A, Lopaschuk GD.
    Curr Pharm Des; 2015 Jul 21; 21(25):3654-64. PubMed ID: 26166604
    [Abstract] [Full Text] [Related]

  • 19. Regulation of energy substrate metabolism in the diabetic heart.
    Stanley WC, Lopaschuk GD, McCormack JG.
    Cardiovasc Res; 1997 Apr 21; 34(1):25-33. PubMed ID: 9217869
    [Abstract] [Full Text] [Related]

  • 20. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.
    Mather KJ, Hutchins GD, Perry K, Territo W, Chisholm R, Acton A, Glick-Wilson B, Considine RV, Moberly S, DeGrado TR.
    Am J Physiol Endocrinol Metab; 2016 Mar 15; 310(6):E452-60. PubMed ID: 26732686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.